DNA Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global DNA Vaccines Market: By Type (Animal DNA vaccine and Human DNA vaccine), By Application (Human disease and Veterinary disease), By Technology (Plasmid DNA vaccines and Plasmid DNA delivery) and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

DNA Vaccines Market size is valued at USD 449.20 million in 2021 and is expected to reach USD 648.31 million by 2028, at a CAGR of 6.25% during the forecast period 2022-2028. Vaccinations consisting of deoxyribonucleic acid, or DNA, are known as DNA vaccines. With few negative effects, this acid can stimulate a wide spectrum of immunological responses and encode antigens in the body. The transport of DNA-based vaccines to cells is followed by the gene’s expression, which results in the production of the needed protein. Clinical trials of numerous DNA vaccines have shown encouraging results in the treatment of many diseases, including pancreatic cancer, prostate carcinoma, metastatic melanoma, and solid tumours. Over the forecast period, rapid acceptance of these vaccinations in the healthcare sector is expected to fuel growth in the global DNA vaccines market. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global DNA Vaccines Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

DNA Vaccines Market

MARKET SUMMARY
-
6.25%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.25%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

DNA Vaccines Market

  • The global DNA Vaccines Market report gives comprehensive outlook on DNA Vaccines Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global DNA Vaccines Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Merck & Co., Inc. (U.S.),
  • Sanofi Pasteur SA (France),
  • Astellas Pharma Inc. (Japan)
  • GlaxoSmithKline, plc (U.K.),
  • Pfizer, Inc. (U.S)
DNA Vaccines Market

DRIVERS AND RESTRAINTS

The global DNA vaccines market is being driven by an increase in incidence of chronic and infectious diseases, rising use of DNA vaccines for animal healthcare, and a surge in the creation of new vaccines. On the other side, difficulties such as a lack of a legal and ethical framework, as well as government laws, limit the market’s expansion. Opportunities such as stable vaccines that are easier to store and transport, an increase in the number of human clinical studies, and an increase in the need for gene therapy all contribute to the market’s growth. Variation in the regulatory process and points of concern about environmental valuation, on the other hand, are proving to be major roadblocks to the expansion of the DNA vaccines industry.


North-America got significant share

DNA Vaccines Market

North America accounted for larger revenue share in global DNA vaccines market with a significant CAGR and is expected to grow over the forecast years is due to the increasing occurrence of infectious diseases in countries such as U.S and Canada. The rise in awareness regarding the benefits among people is expected to drive the market. U.S. and Canada are the major contributors to the market due to prevalence of tempting and continual sickness in animals as well as humans in this region. Asia Pacific held significant market share during estimated period owing to increasing disposable income level and the rising awareness regarding the qualities of vaccination in emerging economies of the Asia Pacific region is further expected to advance market growth.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Global DNA vaccines market expanding at significant CAGR over 2022 to 2028 owing to increasing adoption of DNA vaccines for animal healthcare
  • Based on region, North America accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global DNA vaccines market

Key

Features of the Report

DNA Vaccines Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global DNA Vaccines Market Introduction
    • Global DNA Vaccines Market – Taxonomy
    • Global DNA Vaccines Market –Definitions
      • Type
      • Application
      • Technology
  1. Global DNA Vaccines Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global DNA Vaccines Market Dynamic Factors – Impact Analysis
    • Global DNA Vaccines Market – Competition Landscape
  2. Global DNA Vaccines Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis,2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global DNA Vaccines Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Animal DNA vaccine
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Human DNA vaccine
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Human disease
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Veterinary disease
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market, By Technology, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Plasmid DNA vaccines
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Plasmid DNA delivery
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global DNA Vaccines Market – Opportunity Analysis Index, By Type, Application, Technology and Region, 2020 – 2026
  2. North America DNA Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2015 – 2019and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America DNA Vaccines Market – Opportunity Analysis Index, By Type, Application, Technology and Country, 2020 – 2026
    • North America DNA Vaccines Market Dynamics – Trends
  3. Europe DNA Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2015 – 2019and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe DNA Vaccines Market – Opportunity Analysis Index, By Type, Application, Technology and Country, 2020 – 2026
    • Europe DNA Vaccines Market Dynamics – Trends
  4. Asia-Pacific DNA Vaccines Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2015 – 2019and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of APAC
    • Asia-Pacific DNA Vaccines Market – Opportunity Analysis Index, By Type, Application, Technology and Country,2020 – 2026
    • Asia-Pacific DNA Vaccines Market Dynamics – Trends
  5. Latin America DNA Vaccines Market Analysis,2015 – 2019and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2015 – 2019and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Argentina
      • Mexico
      • Rest of LATAM
    • Latin America DNA Vaccines Market – Opportunity Analysis Index, By Type, Application, Technology and Country, 2020 – 2026
    • Latin America DNA Vaccines Market Dynamics – Trends
  6. Middle East and Africa DNA Vaccines Market Analysis, 2015 – 2019and Forecast, 2020 – 2026(Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2015 – 2019and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • South Africa
      • Turkey
      • GCC Countries
      • Rest of MEA
    • MEA DNA Vaccines Market – Opportunity Analysis Index, By Application, Technology, Application, Deployment Type, and Country, 2020 – 2026
    • MEA DNA Vaccines Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Merck
      • GSK
      • Sanofi
      • Zoties
      • Elanco
      • Boehringer-Ingelheim
      • Indian Immunologicals
      • Plumbline Life Sciences
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Merck & Co., Inc. (U.S.),
  • Sanofi Pasteur SA (France),
  • Astellas Pharma Inc. (Japan)
  • GlaxoSmithKline, plc (U.K.),
  • Pfizer, Inc. (U.S)
  • CSL Limited (Australia),
  • Emergent BioSolutions, Inc. (U.S.),
  • Panacea Biotec (India)
  • Protein Sciences Corporation (U.S)
  • Bavarian Nordic (Denmark)

Report

Ask An Analyst

 

Description

DNA Vaccines Market size is valued at USD 449.20 million in 2021 and is expected to reach USD 648.31 million by 2028, at a CAGR of 6.25% during the forecast period 2022-2028. Vaccinations consisting of deoxyribonucleic acid, or DNA, are known as DNA vaccines. With few negative effects, this acid can stimulate a wide spectrum of immunological responses and encode antigens in the body. The transport of DNA-based vaccines to cells is followed by the gene’s expression, which results in the production of the needed protein. Clinical trials of numerous DNA vaccines have shown encouraging results in the treatment of many diseases, including pancreatic cancer, prostate carcinoma, metastatic melanoma, and solid tumours. Over the forecast period, rapid acceptance of these vaccinations in the healthcare sector is expected to fuel growth in the global DNA vaccines market. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global DNA Vaccines Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX